Other Events ·
BioHarvest Sciences Inc. announced its intention to dual-list its ordinary shares on the Tel Aviv Stock Exchange…
BHSTBioharvest Sciences Inc.
BioHarvest Sciences Inc. announced its intention to dual-list its ordinary shares on the Tel Aviv Stock Exchange (TASE) in addition to its existing Nasdaq listing. Trading on TASE is expected to begin on September 8, 2026, under the symbol BHST. The company registered approximately 22.7 million outstanding common shares for listing, along with up to 4.5 million shares available for future issuance under its Equity Incentive Plan and 610,742 shares issuable upon warrant exercise. This move aims to broaden investor access and strengthen ties with the Israeli investment community. BioHarvest Sciences operates in the biotechnology sector, specializing in botanical synthesis technology to develop plant-based therapeutic solutions and nutraceutical products.